JAN (NYSE:JAN) Receives Consensus Rating of “Moderate Buy” from Brokerages

JAN (NYSE:JAN) has earned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $29.1538.

Several research firms have recently weighed in on JAN. The Goldman Sachs Group began coverage on JAN in a report on Tuesday, April 14th. They set a “neutral” rating and a $27.00 price target on the stock. Cantor Fitzgerald reissued an “overweight” rating and set a $30.00 price target on shares of JAN in a report on Friday, June 12th. Morgan Stanley began coverage on JAN in a report on Tuesday, April 14th. They set an “overweight” rating and a $28.00 price target on the stock. Zacks Research raised JAN to a “hold” rating in a report on Wednesday, April 15th. Finally, KeyCorp increased their price target on JAN from $28.00 to $29.00 and gave the company an “overweight” rating in a report on Wednesday, June 10th.

JAN Price Performance

JAN stock opened at $28.33 on Friday. The company has a market cap of $7.46 billion, a PE ratio of -62.29 and a beta of 2.16. JAN has a 12-month low of $22.76 and a 12-month high of $29.09. The company has a 50 day simple moving average of $26.20.

JAN (NYSE:JAN) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.23 earnings per share for the quarter, meeting the consensus estimate of $0.23. The firm had revenue of $200.35 million for the quarter, compared to the consensus estimate of $157.96 million. JAN has set its FY 2026 guidance at 0.930-0.970 EPS.

JAN Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 24th. Stockholders of record on Friday, June 12th were issued a dividend of $0.1599 per share. This represents a $0.64 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend was Friday, June 12th.

More JAN News

Here are the key news stories impacting JAN this week:

• Neutral Sentiment: Matinas BioPharma (MTNB) received a NYSE American non-compliance notice for insufficient stockholders’ equity, but the exchange accepted its compliance plan and granted it until October 2, 2027 to regain listing standards. Article: Matinas BioPharma Receives NYSE American Notice of Non-Compliance, Granted Plan Period to Regain Listing Standards
• Neutral Sentiment: JAN recently reported EPS in line with estimates and revenue that beat forecasts, which supports the longer-term fundamental case even as the stock has been volatile.

JAN Company Profile

Upon completion of this offering, we will be the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT whose entire portfolio is owned and operated under RIDEA structures. We have an initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. Our communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025.